Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across 4 US Observational Databases

NCT04394234 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT04394234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04394234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across 4 US Observational Databases
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
May 15, 2020
Completion date
June 1, 2020
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine hemorrhage